APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Breast AI-assisted Diagnosis Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Breast AI-assisted Diagnosis Software Market Outlook and Growth Opportunities 2026

Report ID 17408213046 March 2026198 pages

Choose your research edition.

Industry ResearchBreast AI-assisted Diagnosis Software Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Breast AI-assisted Diagnosis Software Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Breast AI-assisted Diagnosis Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Breast AI-assisted Diagnosis Software Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Breast AI-assisted Diagnosis Software Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Breast AI-assisted Diagnosis Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Breast AI-assisted Diagnosis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Breast AI-assisted Diagnosis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Breast AI-assisted Diagnosis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Breast AI-assisted Diagnosis Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Breast AI-assisted Diagnosis Software market include Yizhun, Sense Time, United Imaging, Huiying Medical, BioMind, Infervision, Demetics Medical, GE HealthCare and Kheiron, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Breast AI-assisted Diagnosis Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Breast AI-assisted Diagnosis Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Breast AI-assisted Diagnosis Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Breast AI-assisted Diagnosis Software market.

Breast AI-assisted Diagnosis Software Segment by Company

Yizhun

Sense Time

United Imaging

Huiying Medical

BioMind

Infervision

Demetics Medical

GE HealthCare

Kheiron

Hologic

Densitas

Lunit Inc.

Breast AI-assisted Diagnosis Software Segment by Type

Cloud-based

On-Primes

Breast AI-assisted Diagnosis Software Segment by Application

Hospital

Clinic

Imaging Center

Breast AI-assisted Diagnosis Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Breast AI-assisted Diagnosis Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Breast AI-assisted Diagnosis Software key companies, revenue, market share, and recent developments.

3. To split the Breast AI-assisted Diagnosis Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Breast AI-assisted Diagnosis Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Breast AI-assisted Diagnosis Software significant trends, drivers, influence factors in global and regions.

6. To analyze Breast AI-assisted Diagnosis Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Breast AI-assisted Diagnosis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Breast AI-assisted Diagnosis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Breast AI-assisted Diagnosis Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Breast AI-assisted Diagnosis Software industry.

Chapter 3: Detailed analysis of Breast AI-assisted Diagnosis Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Breast AI-assisted Diagnosis Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Breast AI-assisted Diagnosis Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Breast AI-assisted Diagnosis Software Industry Trends Table 2. Breast AI-assisted Diagnosis Software Industry Drivers Table 3. Breast AI-assisted Diagnosis Software Industry Opportunities and Challenges Table 4. Breast AI-assisted Diagnosis Software Industry Restraints Table 5. Global Breast AI-assisted Diagnosis Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Breast AI-assisted Diagnosis Software Revenue Share by Company (2021-2026) Table 7. Global Breast AI-assisted Diagnosis Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Breast AI-assisted Diagnosis Software Key Company Manufacturing Base & Headquarters Table 9. Global Breast AI-assisted Diagnosis Software Company, Product Type & Application Table 10. Global Breast AI-assisted Diagnosis Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Breast AI-assisted Diagnosis Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud-based Table 15. Significant Companies of On-Primes Table 16. Global Breast AI-assisted Diagnosis Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Breast AI-assisted Diagnosis Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Breast AI-assisted Diagnosis Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Breast AI-assisted Diagnosis Software Sales Value Share by Type (2021-2026) Table 20. Global Breast AI-assisted Diagnosis Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Clinic Table 23. Significant Companies of Imaging Center Table 24. Global Breast AI-assisted Diagnosis Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Breast AI-assisted Diagnosis Software Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Breast AI-assisted Diagnosis Software Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Breast AI-assisted Diagnosis Software Sales Value Share by Application (2021-2026) Table 28. Global Breast AI-assisted Diagnosis Software Sales Value Share by Application (2027-2032) Table 29. Global Breast AI-assisted Diagnosis Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Breast AI-assisted Diagnosis Software Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Breast AI-assisted Diagnosis Software Sales Value Share by Region (2021-2026) Table 32. Global Breast AI-assisted Diagnosis Software Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Breast AI-assisted Diagnosis Software Sales Value Share by Region (2027-2032) Table 34. Global Breast AI-assisted Diagnosis Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Breast AI-assisted Diagnosis Software Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Breast AI-assisted Diagnosis Software Sales Value Market Share by Country (2021-2026) Table 37. Global Breast AI-assisted Diagnosis Software Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Breast AI-assisted Diagnosis Software Sales Value Market Share by Country (2027-2032) Table 39. Yizhun Company Information Table 40. Yizhun Business Overview Table 41. Yizhun Breast AI-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Yizhun Breast AI-assisted Diagnosis Software Product Portfolio Table 43. Yizhun Recent Development Table 44. Sense Time Company Information Table 45. Sense Time Business Overview Table 46. Sense Time Breast AI-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Sense Time Breast AI-assisted Diagnosis Software Product Portfolio Table 48. Sense Time Recent Development Table 49. United Imaging Company Information Table 50. United Imaging Business Overview Table 51. United Imaging Breast AI-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. United Imaging Breast AI-assisted Diagnosis Software Product Portfolio Table 53. United Imaging Recent Development Table 54. Huiying Medical Company Information Table 55. Huiying Medical Business Overview Table 56. Huiying Medical Breast AI-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Huiying Medical Breast AI-assisted Diagnosis Software Product Portfolio Table 58. Huiying Medical Recent Development Table 59. BioMind Company Information Table 60. BioMind Business Overview Table 61. BioMind Breast AI-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. BioMind Breast AI-assisted Diagnosis Software Product Portfolio Table 63. BioMind Recent Development Table 64. Infervision Company Information Table 65. Infervision Business Overview Table 66. Infervision Breast AI-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Infervision Breast AI-assisted Diagnosis Software Product Portfolio Table 68. Infervision Recent Development Table 69. Demetics Medical Company Information Table 70. Demetics Medical Business Overview Table 71. Demetics Medical Breast AI-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Demetics Medical Breast AI-assisted Diagnosis Software Product Portfolio Table 73. Demetics Medical Recent Development Table 74. GE HealthCare Company Information Table 75. GE HealthCare Business Overview Table 76. GE HealthCare Breast AI-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. GE HealthCare Breast AI-assisted Diagnosis Software Product Portfolio Table 78. GE HealthCare Recent Development Table 79. Kheiron Company Information Table 80. Kheiron Business Overview Table 81. Kheiron Breast AI-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Kheiron Breast AI-assisted Diagnosis Software Product Portfolio Table 83. Kheiron Recent Development Table 84. Hologic Company Information Table 85. Hologic Business Overview Table 86. Hologic Breast AI-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Hologic Breast AI-assisted Diagnosis Software Product Portfolio Table 88. Hologic Recent Development Table 89. Densitas Company Information Table 90. Densitas Business Overview Table 91. Densitas Breast AI-assisted Diagnosis Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Densitas Breast AI-assisted Diagnosis Software Product Portfolio Table 93. Densitas Recent Development Table 94. Lunit Inc. Company Information Table 95. Lunit Inc. Business Overview Table 96. Lunit Inc. Breast AI-assisted Diagnosis Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Lunit Inc. Breast AI-assisted Diagnosis Software Product Portfolio Table 98. Lunit Inc. Recent Development Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Breast AI-assisted Diagnosis Software Product Image Figure 2. Global Breast AI-assisted Diagnosis Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Breast AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Breast AI-assisted Diagnosis Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud-based Image Figure 8. On-Primes Image Figure 9. Global Breast AI-assisted Diagnosis Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Breast AI-assisted Diagnosis Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Breast AI-assisted Diagnosis Software Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Imaging Center Image Figure 15. Global Breast AI-assisted Diagnosis Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Breast AI-assisted Diagnosis Software Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Breast AI-assisted Diagnosis Software Sales Value Share by Application (2021-2032) Figure 18. Global Breast AI-assisted Diagnosis Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Breast AI-assisted Diagnosis Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Breast AI-assisted Diagnosis Software Sales Value (2021-2032) & (US$ Million) Figure 21. North America Breast AI-assisted Diagnosis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Breast AI-assisted Diagnosis Software Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Breast AI-assisted Diagnosis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Breast AI-assisted Diagnosis Software Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Breast AI-assisted Diagnosis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Breast AI-assisted Diagnosis Software Sales Value (2021-2032) & (US$ Million) Figure 27. South America Breast AI-assisted Diagnosis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Breast AI-assisted Diagnosis Software Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Breast AI-assisted Diagnosis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-Primes
Applications
  • Hospital
  • Clinic
  • Imaging Center
Companies covered
  • Yizhun
  • Sense Time
  • United Imaging
  • Huiying Medical
  • BioMind
  • Infervision
  • Demetics Medical
  • GE HealthCare
  • Kheiron
  • Hologic
  • Densitas
  • Lunit Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Breast AI-assisted Diagnosis Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Breast AI-assisted Diagnosis Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Breast AI-assisted Diagnosis Software Market Dynamics
  1. 2.1 Breast AI-assisted Diagnosis Software Industry Trends
  2. 2.2 Breast AI-assisted Diagnosis Software Industry Drivers
  3. 2.3 Breast AI-assisted Diagnosis Software Industry Opportunities and Challenges
  4. 2.4 Breast AI-assisted Diagnosis Software Industry Restraints
3 Breast AI-assisted Diagnosis Software Market by Company
  1. 3.1 Global Breast AI-assisted Diagnosis Software Company Revenue Ranking in 2025
  2. 3.2 Global Breast AI-assisted Diagnosis Software Revenue by Company (2021-2026)
  3. 3.3 Global Breast AI-assisted Diagnosis Software Company Ranking (2024-2026)
  4. 3.4 Global Breast AI-assisted Diagnosis Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Breast AI-assisted Diagnosis Software Company Product Type and Application
  6. 3.6 Global Breast AI-assisted Diagnosis Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Breast AI-assisted Diagnosis Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Breast AI-assisted Diagnosis Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Breast AI-assisted Diagnosis Software Market by Type
  1. 4.1 Breast AI-assisted Diagnosis Software Type Introduction
  2. 4.1.1 Cloud-based
  3. 4.1.2 On-Primes
  4. 4.2 Global Breast AI-assisted Diagnosis Software Sales Value by Type
  5. 4.2.1 Global Breast AI-assisted Diagnosis Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Breast AI-assisted Diagnosis Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global Breast AI-assisted Diagnosis Software Sales Value Share by Type (2021-2032)
5 Breast AI-assisted Diagnosis Software Market by Application
  1. 5.1 Breast AI-assisted Diagnosis Software Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Imaging Center
  5. 5.2 Global Breast AI-assisted Diagnosis Software Sales Value by Application
  6. 5.2.1 Global Breast AI-assisted Diagnosis Software Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Breast AI-assisted Diagnosis Software Sales Value by Application (2021-2032)
  8. 5.2.3 Global Breast AI-assisted Diagnosis Software Sales Value Share by Application (2021-2032)
6 Breast AI-assisted Diagnosis Software Regional Value Analysis
  1. 6.1 Global Breast AI-assisted Diagnosis Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Breast AI-assisted Diagnosis Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Breast AI-assisted Diagnosis Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Breast AI-assisted Diagnosis Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Breast AI-assisted Diagnosis Software Sales Value (2021-2032)
  7. 6.3.2 North America Breast AI-assisted Diagnosis Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Breast AI-assisted Diagnosis Software Sales Value (2021-2032)
  10. 6.4.2 Europe Breast AI-assisted Diagnosis Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Breast AI-assisted Diagnosis Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Breast AI-assisted Diagnosis Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Breast AI-assisted Diagnosis Software Sales Value (2021-2032)
  16. 6.6.2 South America Breast AI-assisted Diagnosis Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Breast AI-assisted Diagnosis Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Breast AI-assisted Diagnosis Software Sales Value Share by Country, 2025 VS 2032
7 Breast AI-assisted Diagnosis Software Country-level Value Analysis
  1. 7.1 Global Breast AI-assisted Diagnosis Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Breast AI-assisted Diagnosis Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Breast AI-assisted Diagnosis Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Breast AI-assisted Diagnosis Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Breast AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Breast AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Breast AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yizhun
  2. 8.1.1 Yizhun Company Information
  3. 8.1.2 Yizhun Business Overview
  4. 8.1.3 Yizhun Breast AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yizhun Breast AI-assisted Diagnosis Software Product Portfolio
  6. 8.1.5 Yizhun Recent Developments
  7. 8.2 Sense Time
  8. 8.2.1 Sense Time Company Information
  9. 8.2.2 Sense Time Business Overview
  10. 8.2.3 Sense Time Breast AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sense Time Breast AI-assisted Diagnosis Software Product Portfolio
  12. 8.2.5 Sense Time Recent Developments
  13. 8.3 United Imaging
  14. 8.3.1 United Imaging Company Information
  15. 8.3.2 United Imaging Business Overview
  16. 8.3.3 United Imaging Breast AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 United Imaging Breast AI-assisted Diagnosis Software Product Portfolio
  18. 8.3.5 United Imaging Recent Developments
  19. 8.4 Huiying Medical
  20. 8.4.1 Huiying Medical Company Information
  21. 8.4.2 Huiying Medical Business Overview
  22. 8.4.3 Huiying Medical Breast AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Huiying Medical Breast AI-assisted Diagnosis Software Product Portfolio
  24. 8.4.5 Huiying Medical Recent Developments
  25. 8.5 BioMind
  26. 8.5.1 BioMind Company Information
  27. 8.5.2 BioMind Business Overview
  28. 8.5.3 BioMind Breast AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 BioMind Breast AI-assisted Diagnosis Software Product Portfolio
  30. 8.5.5 BioMind Recent Developments
  31. 8.6 Infervision
  32. 8.6.1 Infervision Company Information
  33. 8.6.2 Infervision Business Overview
  34. 8.6.3 Infervision Breast AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Infervision Breast AI-assisted Diagnosis Software Product Portfolio
  36. 8.6.5 Infervision Recent Developments
  37. 8.7 Demetics Medical
  38. 8.7.1 Demetics Medical Company Information
  39. 8.7.2 Demetics Medical Business Overview
  40. 8.7.3 Demetics Medical Breast AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Demetics Medical Breast AI-assisted Diagnosis Software Product Portfolio
  42. 8.7.5 Demetics Medical Recent Developments
  43. 8.8 GE HealthCare
  44. 8.8.1 GE HealthCare Company Information
  45. 8.8.2 GE HealthCare Business Overview
  46. 8.8.3 GE HealthCare Breast AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GE HealthCare Breast AI-assisted Diagnosis Software Product Portfolio
  48. 8.8.5 GE HealthCare Recent Developments
  49. 8.9 Kheiron
  50. 8.9.1 Kheiron Company Information
  51. 8.9.2 Kheiron Business Overview
  52. 8.9.3 Kheiron Breast AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Kheiron Breast AI-assisted Diagnosis Software Product Portfolio
  54. 8.9.5 Kheiron Recent Developments
  55. 8.10 Hologic
  56. 8.10.1 Hologic Company Information
  57. 8.10.2 Hologic Business Overview
  58. 8.10.3 Hologic Breast AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hologic Breast AI-assisted Diagnosis Software Product Portfolio
  60. 8.10.5 Hologic Recent Developments
  61. 8.11 Densitas
  62. 8.11.1 Densitas Company Information
  63. 8.11.2 Densitas Business Overview
  64. 8.11.3 Densitas Breast AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Densitas Breast AI-assisted Diagnosis Software Product Portfolio
  66. 8.11.5 Densitas Recent Developments
  67. 8.12 Lunit Inc.
  68. 8.12.1 Lunit Inc. Company Information
  69. 8.12.2 Lunit Inc. Business Overview
  70. 8.12.3 Lunit Inc. Breast AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Lunit Inc. Breast AI-assisted Diagnosis Software Product Portfolio
  72. 8.12.5 Lunit Inc. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst